Bartronics India acquires 15% stake in Huwel Life Sciences for Rs. 50 Cr
BIL also holds an option to increase its equity stake by an additional 15%
BIL also holds an option to increase its equity stake by an additional 15%
Funding supports development of first-in-class pan-ROCK inhibitor ROC-101 through Phase 2a clinical testing
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
We are taking Ayurveda to the world as a sustainable healthcare solution: Union Minister Prataprao Jadhav
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
Shantived Hospital generated revenue of around Rs 50 crore in FY2025
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
Subscribe To Our Newsletter & Stay Updated